Mukka Proteins has announced a strategic expansion in its bio-waste processing operations, targeting a fivefold increase in municipal wet waste conversion capacity by December 2027. Moving from its current 200 TPD to 1,000 TPD, the company plans to utilize Black Soldier Fly bioconversion technology to produce insect protein, bio-oils, and organic compost. This move marks a significant diversification into the circular economy and ESG-linked revenue streams, positioning the firm to benefit from growing global demand for sustainable protein alternatives.
Mukka Proteins Targets 1,000 TPD Waste Conversion by 2027
Mukka Proteins plans to scale its wet waste processing from 200 TPD to 1,000 TPD by December 2027.
This expansion leverages Black Soldier Fly bioconversion to create insect-based proteins and organic fertilizers.
Reader Takeaway: New high-growth vertical diversifies revenue, though success depends on executing a major, phased infrastructure ramp-up.
What just happened
Mukka Proteins announced an operational roadmap to scale its municipal wet waste conversion capacity. The company currently processes 200 Tonnes Per Day (TPD) and aims to reach 400 TPD by March 2027, followed by an aggressive target of 1,000 TPD by December 2027. The project utilizes Black Soldier Fly (BSF) bioconversion, a technology that reduces organic waste mass by 80% within two weeks.
Why this matters
This diversification strategy shifts the company beyond its traditional marine protein business into the circular bio-economy. By converting municipal organic waste, Mukka Proteins creates four new revenue streams: high-protein insect meal for aquafeed, feed-grade insect oil, insect frass compost, and bio-stimulants. The move is also aligned with ESG mandates, as the company plans to seek carbon credit verification for diverting waste from landfills and mitigating methane emissions.
What changes now
The company is evolving into a dual-model operation: maintaining its established marine protein processing footprint of 2,91,720 MTPA while aggressively expanding its bioremediation units. Investors will now see the emergence of ESG-linked revenue potential as the company pursues standards like the Verra registry for carbon credits.
Risks to watch
The primary risk lies in the execution of the capacity ramp-up. Scaling from 200 TPD to 1,000 TPD requires significant operational precision and consistent feedstock sourcing from municipal sources. Additionally, the commercial uptake of insect-based protein products in the Indian market remains a long-term monitorable metric.
What to track next
Watch for updates on the March 2027 milestone of 400 TPD capacity and any initial announcements regarding the successful monetization of carbon credits.